Clinical Trial Update: Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2) [Phase 2]

View source ↗

Summary

Phase 2 trial update presenting multi-dose pharmacokinetics and dose-ranging of inositol in premature infants; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Retinopathy of Prematurity

Drugs mentioned

• Inositol (inositol)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Infant, Low Birth Weight | Phase 2 | Status: COMPLETED | Results posted: 2021-03-12